Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Nanotechnology improves minoxidil treatment for hair loss.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Polymeric nanoparticles show promise for treating skin diseases.

Some chemicals absorbed through the skin can cause serious health problems.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Oxidative stress contributes to hair graying and loss as we age.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.